ABSTRACT. PI 3-kinase, an enzyme responsible for the phosphorylation of the D3 position of the inositol ring of phosphatidylinositol (PI), is recognized to be involved in the regulation of many cellular processes such as mitogenic signalling, inhibition of apoptosis, intracellular vesicle trafficking/secretion, regulation of actin and integrin functions and regulation of protein kinases induced by tumour necrosis factor, oncoproteins and ultraviolet light. Here we report the subcellular distribution and the phosphorylative pattern of p85 a subunit of PI 3-kinase in Burkitt lymphomacells exposed to R interferon a treatment. Immunocytochemical analysis of this enzyme, performed by con focal microscopy, revealed an increased expression of this protein at cytoplasmic level after 90 min of interferon a treatment. Western blotting analyses performed on nuclear and cytoplasmic fractions confirmed the overexpression found by con focal microscopy at cytoplasmic level in the 90 min interferon a treated cells still persisting in the 24 hr treated samples. Such an overexpression was paralleled by an increase of tyrosine phosphorylation both at cytoplasmic and nuclear level suggesting that an enhanced requirement for cytoplasmic expression and phosphorylation of PI 3-kinase might be necessary to the cell for regulating some cytoplasmic-nuclear cross talk involved in the control of Burkitt lymphomacell metabolism following interferon a treatment.
Amongthe pathways activated by different exogenous stimuli at plasma membrane level inositol lipids are known to play a pivotal role (2, 12, 23) . Such a signalling system was found also involved in the downstream metabolic events related to the growth inhibitory action of R interferon a in Daudi lymphomacells (5) (6) (7) (8) (9) . Indeed, results on the expression and the activity of different isoforms of phosphatidylinositol phospholipase C (PI-PLC), the enzyme responsible for the hydrolysis of phosphatidylinositolbisphosphate (PIP2) producing the well known second messengers diacylglycerol (DAG) and inositoltriphosphate (IP3), evidenced a peculiar involvement of different PLCisoforms in the cytoplasmic and nuclear compartments in response to interferon treatment (10-1 1). Moreover, amongthe enzymescorrelated to the inositol lipid metabolism activated by cytokine receptor tyrosine kinase, recently phosphatidylinositol 3-kinase (PI 3-kinase), which phosphorylates the D3 position of the inositol ring of phosphatidylinositol (PI) to produce PI3P, PI3,4P2 and PI3,4,5P3, received particular attention as possible regulator of many cellular processes (16) . PI3,4P2 and PI3,4,5P3, are not found in the normal phosphoinositide cycle and do not appear to be substrate for phosphatidylinositol specific phospholipase C, acting themselves directly as second messengers (21) .
PI 3-kinase is a dimeric enzyme characterized by a catalytic pi 10 subunit and a regulatory p85 subunit. The latter lacks catalytic activity, works as an adapter protein with one SH3and two SH2 domains and associates with and serves as substrate for activated growth factor receptor tyrosine kinases, needing to be phosphorylated to switch on its enzymatic activity (3, 4) . Its response to diverse stimuli appears to be also dependent on the receptor and on the cell type involved (1, 13, 14, 15) .
Amongthe cellular responses in which PI 3-kinase is implicated mitogenic signalling, inhibition of apoptosis, intracellular vesicle trafficking/secretion, regulation of actin and integrin function, regulation of protein kinases induced by tumour necrosis factor, oncoproteins and ultraviolet light are included (4, 18, 19, 26 with a 100 x /1.3 NAoil immersion objective. High fluorescence images were obtained by exciting FITG and PI with 488 nm and 514 nm excitation wavelength of the Argon ion laser and using a BP 520 and LP 590 as barrier niters, respectively.
RESULTS AND DISCUSSION
Western blotting analysis of Daudi total lysates indicated that p85 a subunit was discretely expressed in these cells and that the exposure to interferon a produced an overexpression of the protein detectable from 90 min (Fig. la) up to 24 hr (not shown). After the stripping of p85 a subunit and reprobing with antiphosphotyrosine monoclonal antibody (PY20), which recognizes tyrosine phosphorylated proteins, the blot revealed that the enzymeis phosphorylated and therefore presumably active (Fig. lb) . Since the transcriptional activation of genes by a and /3 interferons is known to be mediated by the formation and activation of interferon stimulated gene factor (ISGF3) and its subsequent binding to interferon stimulated response element (ISRE) in the nucleus (24), to determine whether the effect on PI 3-kinase expression and phosphorylation was a downstream event dependent on the activation of ISGF3, we added to the cultures for 15 min, prior to interferon a, the tyrosine protein kinase inhibitor genistein, known to block completely the formation of ISGF3 (15) . Resuits evidenced that, despite the inhibition of ISGF3 activation, the overexpression and phosphorylation of p85 a subunit still occurred. Such a result therefore suggests the possibility of ISGF3 independent pathway(s) responsible for the increased expression and phosphorylation of the enzyme even when the canonical transduction route is inhibited. We next investigated, by means of con focal microscopy, the subcellular expression of the PI 3-kinase and its possible redistribution, if any, in response to interferon a treatment. A faint dotlike fluorescence at nuclear level and a light cytoplasmic positivity at the periphery of the nucleus were observed in control cells. The fluorescent signal became more intense in the cytoplasm of 90 min interferon treated cells and was still detectable in the 24 hr treated sample. In the nucleus, on the other hand, the fluorescence did not undergo substantial changes with respect to the control ( Fig.  2A , B, C).
Whenproteins from the cytoplasmic fraction were electrophoresed and blotted against p85 a subunit, the overexpression of the enzyme, found by meansof con focal microscopy, in 90 min interferon treated samples was confirmed and detectable up to 24 hr (Fig. 3a) . In the nuclear fraction the enzyme apparently did not undergo any modification along the time course of interferon treatment (Fig. 3c) . In order to assess the phosphorylative level of the enzyme in the two fractions, the S i ! i l l S s a g a a 95 Kd à" å ^«^r-<4^p SS u. PY^20 blots were stripped and reprobed with PY20 MoAb. ECLsystem revealed that, relative to controls, the overexpressed cytoplasmic p85 a subunit was also tyrosine phosphorylated (Fig. 3b) . In the nuclear fraction, despite the finding of an unmodified expression, the interferon treatment induced an hyperphosphorylation of the enzyme (Fig. 3d) .
The results here reported therefore indicate that in Burkitt lymphoma cells, besides the evidence of the canonical polyphosphoinositide cycle (5-10), an involvement of PI 3-kinase in the downstream events generated by interferon a must be taken into account. The increased expression of the protein, even in the presence of the inhibition of ISGF3 assembling, allow us to hypothesize that, as already proposed for PLQ-1 in interferon /3 treated human T lymphocytes (20) , an alternative signal transduction pathway, independent of ISGF3-ISRE interaction, might be involved in the stimulation of this enzyme. The significance of such a stimulation needs, anyway, to be still clarified. It is possible that, among the downstream events generated by interferon a treatment in Daudi cells, the overexpression and phosphorylation of PI 3-kinase at cytoplasmic level might be necessary for regulating, through lipid and/or protein kinase activity, some as yet unidentified protein possibly responsible for the activation of the enzymein the nucleus. Otherwise, the hyperphosphorylation of p85 a subunit occurring at nuclear level upon interferon treatment could be the event responsible for the transcription of p85 a new molecules and accounting, in turn, for the overexpression and the activation of the enzymeat cytoplasmic level. In any case, the enhanced expression and phosphorylation of the enzymein response to interferon treatment, appears to be linked to the cell metabolic activities following the transmission of type I interferon signals and possibly related to the regulation of Daudi cell growth.
